Serina Therapeutics Stock Price To Sales
| SER Stock | 4.79 0.64 15.42% |
Serina Therapeutics fundamentals help investors to digest information that contributes to Serina Therapeutics' financial success or failures. It also enables traders to predict the movement of Serina Stock. The fundamental analysis module provides a way to measure Serina Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Serina Therapeutics stock.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 104.48 | 148.28 |
Serina | Price To Sales |
Serina Therapeutics Company Price To Sales Analysis
Serina Therapeutics' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Serina Therapeutics Price To Sales | 18.03 X |
Most of Serina Therapeutics' fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Serina Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Serina Price To Sales Driver Correlations
Understanding the fundamental principles of building solid financial models for Serina Therapeutics is extremely important. It helps to project a fair market value of Serina Stock properly, considering its historical fundamentals such as Price To Sales. Since Serina Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Serina Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Serina Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Serina Price To Sales Historical Pattern
Today, most investors in Serina Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Serina Therapeutics' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Serina Therapeutics price to sales as a starting point in their analysis.
Serina Therapeutics Price To Sales |
| Timeline |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Serina Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, Serina Therapeutics has a Price To Sales of 18.0288 times. This is 15.75% lower than that of the Biotechnology sector and 81.68% lower than that of the Health Care industry. The price to sales for all United States stocks is 57.87% lower than that of the firm.
Serina Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Serina Therapeutics' direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Serina Therapeutics could also be used in its relative valuation, which is a method of valuing Serina Therapeutics by comparing valuation metrics of similar companies.Serina Therapeutics is currently under evaluation in price to sales category among its peers.
Serina Fundamentals
| Return On Asset | -0.45 | ||||
| Profit Margin | (2.21) % | ||||
| Operating Margin | (75.80) % | ||||
| Current Valuation | 62.84 M | ||||
| Shares Outstanding | 8.88 M | ||||
| Shares Owned By Insiders | 58.14 % | ||||
| Shares Owned By Institutions | 2.30 % | ||||
| Number Of Shares Shorted | 27.52 K | ||||
| Price To Sales | 18.03 X | ||||
| Revenue | 142 K | ||||
| EBITDA | (9.78 M) | ||||
| Net Income | (14.8 M) | ||||
| Total Debt | 4.37 M | ||||
| Book Value Per Share | (1.86) X | ||||
| Cash Flow From Operations | (7.8 M) | ||||
| Short Ratio | 1.73 X | ||||
| Earnings Per Share | 0.14 X | ||||
| Market Capitalization | 57.2 M | ||||
| Total Asset | 11.96 M | ||||
| Retained Earnings | (131.01 M) | ||||
| Working Capital | 110.89 K | ||||
| Net Asset | 11.96 M |
About Serina Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Serina Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Serina Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Serina Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Serina Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Serina Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Serina Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Serina Stock
Moving against Serina Stock
| 0.73 | GILD | Gilead Sciences | PairCorr |
| 0.71 | BMY | Bristol Myers Squibb | PairCorr |
| 0.62 | DYAI | Dyadic International | PairCorr |
| 0.53 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
The ability to find closely correlated positions to Serina Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Serina Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Serina Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Serina Therapeutics to buy it.
The correlation of Serina Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Serina Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Serina Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Serina Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Serina Stock Analysis
When running Serina Therapeutics' price analysis, check to measure Serina Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Serina Therapeutics is operating at the current time. Most of Serina Therapeutics' value examination focuses on studying past and present price action to predict the probability of Serina Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Serina Therapeutics' price. Additionally, you may evaluate how the addition of Serina Therapeutics to your portfolios can decrease your overall portfolio volatility.